AstraZeneca - Powering emissions reductions with clean heat and renewable energy

The research, development and production of medicines is an energy intensive process. As part of our transition to net zero, we have announced a series of innovative partnerships which are decarbonising our operations, expanding access to renewable energy and contributing to the circular economy. In the UK and in the US, we will use renewable natural gas (RNG), or biomethane, to supply clean heat to our sites, providing a blueprint to accelerate emissions reductions in industrial sectors. In addition, through our power purchase agreement in Sweden, we are expanding the country’s wind energy capacity.

trees

Advancing clean heat and energy efficiencies in the UK

We have agreed a 15-year partnership in the UK with Future Biogas to establish the first unsubsidised industrial-scale supply of biomethane. This supply of green gas will power our sites in Macclesfield, Cambridge, Luton and Speke. The new biomethane plant will add renewable energy capacity to existing UK infrastructure and supply more than 100 gigawatt hours (GWh) of biomethane, equivalent to the heat needs of more than 8,000 homes.

Using crops grown locally as part of diverse crop rotations, the plant will also contribute to the development of a circular economy, supporting UK farms with sustainable land management practices.

Read full press release below 

Image: Fahroni, Canva 



Read more

Looking for something specific?